+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In Vitro Diagnostics Market - Global Outlook & Forecast 2023-2028

  • PDF Icon

    Report

  • 402 Pages
  • February 2023
  • Region: Global
  • Arizton
  • ID: 5733619
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global in vitro diagnostics market size is expected to grow at a CAGR of 3.26% during 2022-2028. The IVD market offers advanced, cost-effective, and fast tools that enable precise diagnosis and point-of-care testing or self-testing. The market has moved from conventional instruments to advanced analyzers that need a small volume of samples and high-throughput screening methodologies. These advances, combined with AI and cloud technology, revolutionize the in vitro diagnostics market. The low-volume sample analysis, automation, high-throughput analysis, rapid analysis times, small footprint, low cost, portability, and disposability are key trends in the IVD market.

MARKET TRENDS & OPPORTUNITIES

Advances in Molecular Diagnostics Transforming the Future of Healthcare

The healthcare industry witnessed high development and growth in invitro diagnostics over the past decade. Advances in molecular diagnostics are dramatically improving medical treatment outcomes in current times. Due to drug failure in clinical trials and regulatory barriers, bio-pharmaceutical companies are turning toward new medical solutions at the molecular level and molecular diagnostics. In addition, next-generation sequencing and clustered regularly interspaced short palindromic repeats (CRISPER) technology significantly improve molecular diagnostics for oncology and infectious diseases care. Such factors are expected to lead the in vitro diagnostics market in the future.

Increasing Product Launches & Mergers & Acquisitions in IVD

IVD diagnostics is among the biggest industries to witness several product launches in recent years. The increasing demand for new diagnostics tests forces us to develop new solutions. Currently, the IVD players are operating in a world that designs, develops, manufactures, and sells best-in-class solutions. COVID-19 is one of the best periods where several companies have come forward to develop rapid test kits to detect coronavirus.

In the first half of 2021, IVD companies reported high revenues due to COVID-19 testing. However, in the year's second half, many companies experienced low demand for COVID-19 testing, resulting in decreased COVID-19 product revenue. In the same period, to increase the production and expansion of distribution networks, IVD companies adopted M&A strategies. To prepare for COVID-19, some major and emerging IVD companies have turned to M&As to increase their diagnostic testing portfolio. These acquisitions witnessed the in vitro diagnostics market expansion and portfolio expansion.

A large patient population with chronic and infectious diseases drives the demand for IVD solutions and fuels market growth.

Chronic diseases such as cancer, diabetes, cardiovascular diseases, and others are public health concerns worldwide, resulting in high demand for diagnostic services. In addition, infectious diseases, such as HIV, COVID-19, influenza, staphylococcus, respiratory syncytial virus, and others, pose significant demand for diagnostic services and fuel market growth.

The adoption of advanced technologies in IVD drives significant IVD testing worldwide without experiencing the burden of time and cost. Moreover, they have increased the efficiency of diagnostics and delivered the most accurate results that accelerate market growth. Advances, such as a new generation of IVD products with AI and the digital platform, provide newer dimensions in the global in vitro diagnostics market.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCTS AND SERVICES

The reagent and consumables are the largest segments, accounting for 66.47% of the global in vitro diagnostics market in 2022. Reagents and consumables are used in IVD procedures as a medium and transporter of specimens of patients with medical conditions for diagnosis, treatments, and monitoring. The reoccurring use of reagents and consumables is driving the market growth. Innovation in consumables, especially reagents, is low compared to analyzers. Some companies do come up with new types of reagents for unique products. For instance, Sysmex, a Japanese company, developed a concentrated reagent for hematology analyzers. These concentrated reagents are gaining traction in the market, especially in developed countries. This is helping the company to gain market share. End-users are shifting toward concentrated reagents, which have more benefits than conventional reagents.

Segmentation By Product & Services

  • Reagents and Consumables
  • Instruments/ Analyzers & Software
  • Services

INSIGHTS BY TECHNOLOGY

The global in vitro diagnostics market is segmented into immuno & clinical chemistry, molecular testing, hematology, microbiology & cytology, point- and others by technology. In 2022, the immune & clinical chemistry segment accounted for 45.26% market share of the global IVD market and dominated the other segments. Immunoassay and clinical chemistry are technologies that experience high usage in IVD. These technologies are mostly used to diagnose infectious and chronic diseases that significantly burden global healthcare services. The patient population with chronic and infectious diseases drives the segmental growth of immunochemistry-based IVD solutions. Furthermore, clinical chemistry has wide applications in detecting cancer, diabetes, heart disease, renal disease, liver disorders, and other health conditions that accelerate segmental growth.

Segmentation By Technology

  • Immuno and Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Microbiology and Cytology
  • Others Technology

INSIGHTS BY APPLICATION

In 2022, in vitro diagnostics applications for infectious diseases accounted for 46.95% market share. The global IVD market application is segmented into infectious diseases, diabetes, cardiology, oncology, autoimmune diseases, nephrology, drug testing, and others by application. During the COVID-19 pandemic, more than 3 to 4 billion tests were conducted worldwide, which fueled the growth of the in-vitro diagnostics market. In addition, HIV, influenza, respiratory syncytial virus, and other infectious diseases drive the demand for IVD and boost industry growth. With the increasing burden of infectious diseases, the demand for diagnosis and treatment continues to rise, thus driving the demand for IVD solutions. In recent years, the development in technologies and increasing integration of new technologies for infectious disease diagnosis have led the market to witness high revenue generation through the infectious diseases segment.

Segmentation By Application

  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Oncology
  • Autoimmune Diseases
  • Nephrology
  • Drug Testing
  • Others

INSIGHTS BY END-USERS

The standard reference labs dominated the end-user segment in the global in vitro diagnostics market and was valued at USD 36 billion in 2022 and is expected to grow impressively by 2028. Standard reference laboratories offer several types of IVD services. In recent years, standard reference laboratories have rapidly expanded in LMICs to offer numerous tests and deliver high market growth through adopting new technologies and product offerings. Standard reference laboratories expand their network in a particular region or concentrated areas and deliver easy access to diagnostic services at affordable prices. In addition, the broad range of diagnosis services increases access to several tests that attract a high consumer base and generate significant revenue. In 2022, the standard reference labs segment accounted for 34.21% of the global IVD market.

Hospitals are the primary source and first point of contact for disease diagnosis and cure. In contrast, hospital-associated laboratories account for the high number of IVD practices and drive segmental growth. Globally, the number of hospitals and associated laboratories, growing infrastructure, and increasing healthcare expenditure are some factors that increase the demand for IVD practices through hospitals.

Segmentation By End-Users

  • Standard Reference Labs
  • Hospital-Affiliated Labs
  • Individuals
  • Clinics
  • Others

GEOGRAPHICAL ANALYSIS

In 2022, North America dominated the global IVD market accounting for a 39.90% share. A large patient population base with high healthcare expenditures accelerates the region's market growth. In addition, the awareness of disease diagnosis, such as point-of-care, early detection, and preventive health check-ups, are some factors that majorly and positively impact the industry growth in the region. More than 60% to 80% of the regional population have chronic conditions that demand diagnostics services. Expenditure on healthcare services in the region accounted for approximately USD 4.3 trillion and above in 2021, which grew by 2.7% from 2020, indicating a high potential for market growth. Some leading companies, such as Abbott, BD, Bio-Rad Laboratories, and Biomerieux SA, have higher market penetration in the region, especially in the US. They are increasing access to IVD components and accounting for high revenue generation in the country.

Europe is one of the leading and major regions for the IVD market, which accounts for a significant demand for IVD solutions. The factors responsible for the increasing demand for IVD solutions are the growing aging population in the region, with chronic and infectious diseases driving the high demand for IVD solutions. Across Europe, more than 25,000 pathologists are available, while the UK accounts for 40 pathologists per million population.

Segmentation by Geography

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • Russia
  • Spain
  • Italy
  • UK
  • APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Singapore
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa

COMPETITIVE LANDSCAPE

The leading players in the global in vitro diagnostics market are F Hoffmann-La Roche, Abbott, Thermo Fisher Scientific, and Siemens Healthineers, which are competing with rapidly emerging market players. Vendors are increasing their industry market share through inorganic growth and a constant product launch, helping the vendors acquire new customers. Abbot is one of the leading companies in the global in vitro diagnostics market and is a pioneer in point-of-care diagnostics with a comprehensive portfolio of tests and systems. Its diagnostic products segment offers core laboratory analyzers and biomarkers (clinical chemistry), immunoassay, hematology, and transfusion. In 2021, the company achieved around USD 15.6 billion in revenue, respectively.

Recent Developments in The Global In Vitro Diagnostics Market

  • In March 2020, Abbott’s rapid diagnostic segment launched a molecular test solution to detect COVID-19 with its ID NOW rapid POC in the US.
  • Hoffmann-La Roche invested significantly in R&D activities to develop innovative IVD test solutions. For instance, in FY2019, the company invested about $12.86 billion in R&D activities.
  • In July 2019, Siemens Healthineers completed the acquisition of Minicare B.V. Minicare is developing technology for point-of-care immunoassay testing. The business is being integrated into the Diagnostics segment and will allow Siemens Healthineers to strengthen its portfolio in the rapid diagnostics domain.

Key Company Profiles

  • Abbott
  • Danaher
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Atomo Diagnostics
  • Accelerate Diagnostics
  • Agilent Technologies
  • altona Diagnostics
  • Amoy Diagnostics
  • ARKRAY
  • AccuBioTech
  • Agappe Diagnostics
  • BD
  • Bio-Rad Laboratories
  • Balio diagnostics
  • B&E BIO-TECHNOLOGY
  • BIOMÉRIEUX
  • bioLytical Laboratories
  • Biosynex
  • Biocartis
  • Biocept
  • Biohit Oyj
  • Biomerica
  • Biosystems
  • Bioway Biological Technology
  • Boule Diagnostics
  • Cupid Limited
  • CareDx
  • Chembio Diagnostics
  • CLINDIAG SYSTEMS
  • CONTEC MEDICAL SYSTEMS
  • Convergent Technologies
  • CPC Diagnostics
  • CPM Scientifica
  • CellaVision
  • DIALAB
  • Dexcom
  • DiaSorin
  • Diagon
  • Diatron
  • DIRUI
  • Drucker Diagnostics
  • EDAN Instruments
  • EKF Diagnostics Holdings
  • ELITechGroup
  • Erba Diagnostics
  • Genetron Holdings
  • Genrui Biotech
  • Hologic
  • High Technology
  • HORIBA
  • Linear Chemicals
  • Illumina
  • INTEC
  • J. Mitra & Co.
  • Kilpest India Limited
  • Maccura Biotechnology
  • Medsource Ozone Biomedicals
  • Meril Life Sciences
  • MP Biomedicals
  • Nanjing Synthgene Medical Technology
  • NIHON KOHDEN
  • Norma Instruments
  • NOWDiagnostics
  • Ortho Clinical Diagnostics
  • OPKO Health
  • OraSure Technologies
  • Perkin Elmer
  • Prestige Diagnostics
  • QIAGEN
  • Quidel
  • Sysmex
  • Salofa Oy
  • SEASUN BIOMATERIALS
  • Sekisui Diagnostics
  • SFRI
  • Shenzhen Dymind Biotechnology
  • Shenzhen iCubio Biomedical Technology
  • Shenzhen Mindray Bio-Medical Electronics
  • SHENZHEN PROKAN ELECTRONICS
  • Shenzhen Landwind Medical
  • Sinocare
  • SPINREACT
  • SureScreen Diagnostics
  • The Binding Site Group
  • Trinity Biotech
  • Trivitron Healthcare
  • Xiamen Biotime Biotechnology
  • Zhejiang Orient Gene Biotech

KEY QUESTIONS ANSWERED:

1. How big is the In Vitro Diagnostics Market?
2. What is the growth rate of the in vitro diagnostics market?
3. Who are the key players in the global in vitro diagnostics market?
4. Which region holds the most significant global in vitro diagnostics market share?
5. What are the growing trends in the in vitro diagnostics market?

Table of Contents


1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market by Product & Services:
4.3.2 Market by Technology
4.3.3 Market by Application
4.3.4 Market by End-Users
4.3.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Premium Insights
7.1 Overview
8 Introduction
8.1 Overview

9 Market Opportunities & Trends
9.1 Advances in Molecular Diagnostics Transforming the Future of Healthcare
9.2 Increased Demand for Companion Diagnostics in Ivd
9.3 Increasing Product Launches & Mergers & Acquisitions in Ivd
10 Market Growth Enablers
10.1 Presence of a Significant Patient Population
10.2 Adoption of Advanced Technologies in Ivd
10.3 COVID-19 Impact on Ivd Market
11 Market Restraints
11.1 Stringent Regulations and Associated Challenges
11.2 High Cost of Ivd
11.3 Lack of Access to Diagnostic Services and Associated Challenges
12 Market Landscape
12.1 Market Overview
12.1.1 Insight by Product & Services
12.1.2 Insight by Technology
12.1.3 Insight by Application
12.1.4 Insight by End-Users
12.1.5 Insight by Geography
12.2 Market Size & Forecast
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry
13 Product & Services
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Reagents and Consumables
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Market by Geography
13.4 Instruments/Analyzers & Software
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Market by Geography
13.5 Services
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Market by Geography
14 Technology
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Immuno & Clinical Chemistry
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Market by Geography
14.4 Molecular Diagnostics
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Market by Geography
14.5 Hematology
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Market by Geography
14.6 Microbiology & Cytology
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Market by Geography
14.7 Others
14.7.1 Market Overview
14.7.2 Market Size & Forecast
14.7.3 Market by Geography
15 Application
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Infectious Diseases
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Market by Geography
15.4 Diabetes
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Market by Geography
15.5 Cardiology
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Market by Geography
15.6 Oncology
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.6.3 Market by Geography
15.7 Autoimmune Disease
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.7.3 Market by Geography
15.8 Nephrology
15.8.1 Market Overview
15.8.2 Market Size & Forecast
15.8.3 Market by Geography
15.9 Drug Testing
15.9.1 Market Overview
15.9.2 Market Size & Forecast
15.9.3 Market by Geography
15.10 Others
15.10.1 Market Overview
15.10.2 Market Size & Forecast
15.10.3 Market by Geography
16 End-Users
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Standard Reference Labs
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.3.3 Market by Geography
16.4 Hospital-Affiliated Labs
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.4.3 Market by Geography
16.5 Individuals
16.5.1 Market Overview
16.5.2 Market Size & Forecast
16.5.3 Market by Geography
16.6 Clinics
16.6.1 Market Overview
16.6.2 Market Size & Forecast
16.6.3 Market by Geography
16.7 Others
16.7.1 Market Overview
16.7.2 Market Size & Forecast
16.7.3 Market by Geography
17 Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview
18 North America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Product & Services
18.3.1 Market Size & Forecast
18.4 Technology
18.4.1 Market Size & Forecast
18.5 Application
18.5.1 Market Size & Forecast
18.6 End-User
18.6.1 Market Size & Forecast
18.7 Key Countries
18.7.1 Us: Market Size & Forecast
18.7.2 Canada: Market Size & Forecast
19 Europe
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Product & Services
19.3.1 Market Size & Forecast
19.4 Technology
19.4.1 Market Size & Forecast
19.5 Application
19.5.1 Market Size & Forecast
19.6 End-User
19.6.1 Market Size & Forecast
19.7 Key Countries
19.7.1 Germany: Market Size & Forecast
19.7.2 France: Market Size & Forecast
19.7.3 Russia: Market Size & Forecast
19.7.4 Spain: Market Size & Forecast
19.7.5 Italy: Market Size & Forecast
19.7.6 Uk: Market Size & Forecast
20 APAC
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Product & Services
20.3.1 Market Size & Forecast
20.4 Technology
20.4.1 Market Size & Forecast
20.5 Application
20.5.1 Market Size & Forecast
20.6 End-User
20.6.1 Market Size & Forecast
20.7 Key Countries
20.7.1 China: Market Size & Forecast
20.7.2 Japan: Market Size & Forecast
20.7.3 India: Market Size & Forecast
20.7.4 South Korea: Market Size & Forecast
20.7.5 Australia: Market Size & Forecast
20.7.6 Indonesia: Market Size & Forecast
20.7.7 Malaysia Market Size & Forecast
20.7.8 Singapore Market Size & Forecast
21 Latin America
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Product & Services
21.3.1 Market Size & Forecast
21.4 Technology
21.4.1 Market Size & Forecast
21.5 Application
21.5.1 Market Size & Forecast
21.6 End-User
21.6.1 Market Size & Forecast
21.7 Key Countries
21.7.1 Brazil: Market Size & Forecast
21.7.2 Mexico: Market Size & Forecast
21.7.3 Argentina: Market Size & Forecast
22 Middle East & Africa
22.1 Market Overview
22.2 Market Size & Forecast
22.3 Product & Services
22.3.1 Market Size & Forecast
22.4 Technology
22.4.1 Market Size & Forecast
22.5 Application
22.5.1 Market Size & Forecast
22.6 End-User
22.6.1 Market Size & Forecast
22.7 Key Countries
22.7.1 Turkey: Market Size & Forecast
22.7.2 Saudi Arabia: Market Size & Forecast
22.7.3 South Africa: Market Size & Forecast
23 Competitive Landscape
23.1 Competition Overview
23.2 Market Share Analysis
23.2.1 Abbott
23.2.2 Danaher
23.2.3 F. Hoffmann-La Roche
23.2.4 Siemens Healthineers
23.2.5 Thermo Fisher Scientific
24 Key Company Profiles
24.1 Abbott
24.1.1 Business Overview
24.1.2 Product Offerings
24.1.3 Key Strategies
24.1.4 Key Strengths
24.1.5 Key Opportunities
24.2 Danaher
24.2.1 Business Overview
24.2.2 Product Offerings
24.2.3 Key Strategies
24.2.4 Key Strengths
24.2.5 Key Opportunities
24.3 F. Hoffmann-La Roche
24.3.1 Business Overview
24.3.2 Product Offerings
24.3.3 Key Strategies
24.3.4 Key Strengths
24.3.5 Key Opportunities
24.4 Siemens Healthineers
24.4.1 Business Overview
24.4.2 Product Offerings
24.4.3 Key Strategies
24.4.4 Key Strengths
24.4.5 Key Opportunities
24.5 Thermo Fisher Scientific
24.5.1 Business Overview
24.5.2 Product Offerings
24.5.3 Key Strategies
24.5.4 Key Strengths
24.5.5 Key Opportunities
25 Other Prominent Vendors
25.1 Atomo Diagnostics
25.1.1 Business Overview
25.1.2 Product Offerings
25.2 Accelerate Diagnostics
25.2.1 Business Overview
25.2.2 Product Offerings
25.3 Agilent Technologies
25.3.1 Business Overview
25.3.2 Product Offerings
25.4 Altona Diagnostics
25.4.1 Business Overview
25.4.2 Product Offerings
25.5 Amoy Diagnostics
25.5.1 Business Overview
25.5.2 Product Offerings
25.6 Arkray
25.6.1 Business Overview
25.6.2 Product Offerings
25.7 Accubiotech
25.7.1 Business Overview
25.7.2 Product Offerings
25.8 Agappe Diagnostics
25.8.1 Business Overview
25.8.2 Product Offerings
25.9 Bd
25.9.1 Business Overview
25.9.2 Product Offerings
25.10 Bio-Rad Laboratories
25.10.1 Business Overview
25.10.2 Product Offerings
25.11 Balio Diagnostics
25.11.1 Business Overview
25.11.2 Product Offerings
25.12 B&E Bio-Technology
25.12.1 Business Overview
25.12.2 Product Offerings
25.13 Biomérieux
25.13.1 Business Overview
25.13.2 Product Offerings
25.14 Biolytical Laboratories
25.14.1 Business Overview
25.14.2 Product Offerings
25.15 Biosynex
25.15.1 Business Overview
25.15.2 Product Offerings
25.16 Biocartis
25.16.1 Business Overview
25.16.2 Product Offerings
25.17 Biocept
25.17.1 Business Overview
25.17.2 Product Offerings
25.18 Biohit Oyj
25.18.1 Business Overview
25.18.2 Product Offerings
25.19 Biomerica
25.19.1 Business Overview
25.19.2 Product Offerings
25.20 Biosystem
25.20.1 Business Overview
25.20.2 Product Offerings
25.21 Bioway Biological Technology
25.21.1 Business Overview
25.21.2 Product Offerings
25.22 Boule Diagnostics
25.22.1 Business Overview
25.22.2 Product Offerings
25.23 Cupid Limited
25.23.1 Business Overview
25.23.2 Product Offerings
25.24 Caredx
25.24.1 Business Overview
25.24.2 Product Offerings
25.25 Chembio Diagnostics
25.25.1 Business Overview
25.25.2 Product Offerings
25.26 Clindiag Systemsa
25.26.1 Business Overview
25.26.2 Product Offerings
25.27 Contec Medical Systems
25.27.1 Business Overview
25.27.2 Product Offerings
25.28 Convergent Technologies
25.28.1 Business Overview
25.28.2 Product Offerings
25.29 Cpc Diagnostics
25.29.1 Business Overview
25.29.2 Product Offerings
25.30 Cpm Scientifica
25.30.1 Business Overview
25.30.2 Product Offerings
25.31 Cellavision
25.31.1 Business Overview
25.31.2 Product Offerings
25.32 Dialab
25.32.1 Business Overview
25.32.2 Product Offerings
25.33 Dexcom
25.33.1 Business Overview
25.33.2 Product Offerings
25.34 Diasorin
25.34.1 Business Overview
25.34.2 Product Offerings
25.35 Diagon
25.35.1 Business Overview
25.35.2 Product Offerings
25.36 Diatron
25.36.1 Business Overview
25.36.2 Product Offerings
25.37 Dirui
25.37.1 Business Overview
25.37.2 Product Offerings
25.38 Drucker Diagnostics
25.38.1 Business Overview
25.38.2 Product Offerings
25.39 Edan Instruments
25.39.1 Business Overview
25.39.2 Product Offerings
25.40 Ekf Diagnostics Holding
25.40.1 Business Overview
25.40.2 Product Offerings
25.41 Elitechgroup
25.41.1 Business Overview
25.41.2 Product Offerings
25.42 Erba Diagnostics
25.42.1 Business Overview
25.42.2 Product Offerings
25.43 Genetron Holdings
25.43.1 Business Overview
25.43.2 Product Offerings
25.44 Genrui Biotech
25.44.1 Business Overview
25.44.2 Product Offerings
25.45 Hologic
25.45.1 Business Overview
25.45.2 Product Offerings
25.46 High Technology
25.46.1 Business Overview
25.46.2 Product Offerings
25.47 Horiba
25.47.1 Business Overview
25.47.2 Product Offerings
25.48 Linear Chemicals
25.48.1 Business Overview
25.48.2 Product Offerings
25.49 Illumina
25.49.1 Business Overview
25.49.2 Product Offerings
25.50 Intec
25.50.1 Business Overview
25.50.2 Product Offerings
25.51 J. Mitra & Co.
25.51.1 Business Overview
25.51.2 Product Offerings
25.52 Kilpest India Limited
25.52.1 Business Overview
25.52.2 Product Offerings
25.53 Maccura Biotechnology
25.53.1 Business Overview
25.53.2 Product Offerings
25.54 Medsource Ozone Biomedicals
25.54.1 Business Overview
25.54.2 Product Offerings
25.55 Meril Life Sciences
25.55.1 Business Overview
25.55.2 Product Offerings
25.56 Mp Biomedicals
25.56.1 Business Overview
25.56.2 Product Offerings
25.57 Nanjing Synthgene Medical Technology
25.57.1 Business Overview
25.57.2 Product Offerings
25.58 Nihon Kohden
25.58.1 Business Overview
25.58.2 Product Offerings
25.59 Norma Instruments
25.59.1 Business Overview
25.59.2 Product Offerings
25.60 Nowdiagnostics
25.60.1 Business Overview
25.60.2 Product Offerings
25.61 Ortho Clinical Diagnostics
25.61.1 Business Overview
25.61.2 Product Offerings
25.62 Opko Health (Bioreference Health)
25.62.1 Business Overview
25.62.2 Product Offerings
25.63 Orasure Technologies
25.63.1 Business Overview
25.63.2 Product Offerings
25.64 Perkin Elmer
25.64.1 Business Overview
25.64.2 Product Offerings
25.65 Prestige Diagnostics
25.65.1 Business Overview
25.65.2 Product Offerings
25.66 Qiagen
25.66.1 Business Overview
25.66.2 Product Offerings
25.67 Quidel
25.67.1 Business Overview
25.67.2 Product Offerings
25.68 Sysmex
25.68.1 Business Overview
25.68.2 Product Offerings
25.69 Salofa Oy
25.69.1 Business Overview
25.69.2 Product Offerings
25.70 Seasun Biomaterials
25.70.1 Business Overview
25.70.2 Product Offerings
25.71 Sekisui Diagnostics
25.71.1 Business Overview
25.72 Sfri
25.72.1 Business Overview
25.72.2 Product Offerings
25.73 Shenzhen Dymind Biotechnology
25.73.1 Business Overview
25.73.2 Product Offerings
25.74 Shenzhen Icubio Biomedical Technology
25.74.1 Business Overview
25.74.2 Product Offerings
25.75 Shenzhen Mindray Bio-Medical Electronics
25.75.1 Business Overview
25.75.2 Product Offerings
25.76 Shenzhen Prokan Electronics
25.76.1 Business Overview
25.76.2 Product Offerings
25.77 Shenzhen Landwind Medical
25.77.1 Business Overview
25.77.2 Product Offerings
25.78 Sinocare
25.78.1 Business Overview
25.78.2 Product Offerings
25.79 Spinreact
25.79.1 Business Overview
25.79.2 Product Offerings
25.80 Surescreen Diagnostics
25.80.1 Business Overview
25.80.2 Product Offerings
25.81 the Binding Site Group
25.81.1 Business Overview
25.81.2 Product Offerings
25.82 Trinity Biotech
25.82.1 Business Overview
25.82.2 Product Offerings
25.83 Trivitron Healthcare
25.83.1 Business Overview
25.83.2 Product Offerings
25.84 Xiamen Biotime Biotechnology
25.84.1 Business Overview
25.84.2 Product Offerings
25.85 Zhejiang Orient Gene Biotech
25.85.1 Business Overview
25.85.2 Product Offerings
26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations
27 Quantitative Summary
27.1 Market by Geography
27.2 Market by Product & Services
27.3 Market by Technology
27.4 Market by Application
27.5 Market by End-Users
27.6 Product & Services: Market by Geography
27.6.1 Reagents & Consumables: Market by Geography
27.6.2 Instruments/Analyzers & Software: Market by Geography
27.6.3 Services: Market by Geography
27.7 Technology: Market by Geography
27.7.1 Immuno & Clinical Chemistry: Market by Geography
27.7.2 Molecular Diagnostics: Market by Geography
27.7.3 Hematology: Market by Geography
27.7.4 Microbiology & Cytology: Market by Geography
27.7.5 Other Technologies: Market by Geography
27.8 Application: Market by Geography
27.8.1 Infectious Diseases: Market by Geography
27.8.2 Diabetes: Market by Geography
27.8.3 Cardiology: Market by Geography
27.8.4 Oncology: Market by Geography
27.8.5 Autoimmune Diseases: Market by Geography
27.8.6 Nephrology: Market by Geography
27.8.7 Drug Testing: Market by Geography
27.8.8 Other Applications: Market by Geography
27.9 End-Users: Market by Geography
27.9.1 Standard Reference Labs: Market by Geography
27.9.2 Hospital Affiliated Labs: Market by Geography
27.9.3 Individuals: Market by Geography
27.9.4 Clinics: Market by Geography
27.9.5 Other End-Users: Market by Geography
28 Appendix
28.1 Abbreviations

Companies Mentioned

  • Abbott
  • Danaher
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Atomo Diagnostics
  • Accelerate Diagnostics
  • Agilent Technologies
  • altona Diagnostics
  • Amoy Diagnostics
  • ARKRAY
  • AccuBioTech
  • Agappe Diagnostics
  • BD
  • Bio-Rad Laboratories
  • Balio diagnostics
  • B&E BIO-TECHNOLOGY
  • BIOMÉRIEUX
  • bioLytical Laboratories
  • Biosynex
  • Biocartis
  • Biocept
  • Biohit Oyj
  • Biomerica
  • Biosystems
  • Bioway Biological Technology
  • Boule Diagnostics
  • Cupid Limited
  • CareDx
  • Chembio Diagnostics
  • CLINDIAG SYSTEMS
  • CONTEC MEDICAL SYSTEMS
  • Convergent Technologies
  • CPC Diagnostics
  • CPM Scientifica
  • CellaVision
  • DIALAB
  • Dexcom
  • DiaSorin
  • Diagon
  • Diatron
  • DIRUI
  • Drucker Diagnostics
  • EDAN Instruments
  • EKF Diagnostics Holdings
  • ELITechGroup
  • Erba Diagnostics
  • Genetron Holdings
  • Genrui Biotech
  • Hologic
  • High Technology
  • HORIBA
  • Linear Chemicals
  • Illumina
  • INTEC
  • J. Mitra & Co.
  • Kilpest India Limited
  • Maccura Biotechnology
  • Medsource Ozone Biomedicals
  • Meril Life Sciences
  • MP Biomedicals
  • Nanjing Synthgene Medical Technology
  • NIHON KOHDEN
  • Norma Instruments
  • NOWDiagnostics
  • Ortho Clinical Diagnostics
  • OPKO Health
  • OraSure Technologies
  • Perkin Elmer
  • Prestige Diagnostics
  • QIAGEN
  • Quidel
  • Sysmex
  • Salofa Oy
  • SEASUN BIOMATERIALS
  • Sekisui Diagnostics
  • SFRI
  • Shenzhen Dymind Biotechnology
  • Shenzhen iCubio Biomedical Technology
  • Shenzhen Mindray Bio-Medical Electronics
  • SHENZHEN PROKAN ELECTRONICS
  • Shenzhen Landwind Medical
  • Sinocare
  • SPINREACT
  • SureScreen Diagnostics
  • The Binding Site Group
  • Trinity Biotech
  • Trivitron Healthcare
  • Xiamen Biotime Biotechnology
  • Zhejiang Orient Gene Biotech

Methodology


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



 

Loading
LOADING...

Table Information